Proto Axiom
Overview
Proto Axiom is an Australian biotechnology incubator and investment firm that provides early-stage funding and hands-on support to guide scientific breakthroughs from proof-of-concept to commercial success.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| JumpStart Fertility | Jun 2025 | Seed | Lead |
| Swan Genomics | Sep 2023 | Pre Seed | Lead |
| AdvanCell | Jul 2026 | Series D | Co-investor |
| Endo Axiom | Apr 2023 | Seed | Lead |
Key People
Anthony Liveris
Chief Executive Officer
John Roach
Chief Financial Officer
Hugh Mc Gonagle
Chief Operating Officer
Anthony Haddad
Shareholder Strategic Partnerships Lead
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Proto Axiom based?
Proto Axiom is headquartered in North Sydney, New South Wales, Australia.
When was Proto Axiom founded?
Proto Axiom was founded in 2021.
How many portfolio companies does Proto Axiom have?
Proto Axiom has 4 portfolio companies in Caplight's dataset.
What are some companies in Proto Axiom's portfolio?
Portfolio companies visible on Caplight include JumpStart Fertility, Swan Genomics, AdvanCell, Endo Axiom.
What was Proto Axiom's most recent investment shown here?
Proto Axiom's most recent investment in this portfolio sample was in AdvanCell in 2026.
What sectors does Proto Axiom focus on?
Proto Axiom focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Proto Axiom focus on?
Proto Axiom typically invests at the Early stage.
What is Proto Axiom's AUM?
Proto Axiom's assets under management are estimated between $45.0M and $45.0M.